NARA Discovery
Article Details
← Back to Search Results
Journal Article

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population

Kathleen F. Mittendorf; Chinedu Ukaegbu; Marian J. Gilmore; Nangel M. Lindberg; Tia L. Kauffman; Donna J. Eubanks; Elizabeth Shuster; Jake Allen; Carmit McMullen; Heather Spencer Feigelson; Katherine P. Anderson; Michael C. Leo; Jessica Ezzell Hunter; Sonia Okuyama Sasaki; Jamilyn M. Zepp; Sapna Syngal; Benjamin S. Wilfond; Katrina A. B. Goddard
Familial Cancer · Vol. 21, Issue 2 · pp. 167-180 · 2022

Abstract

Lynch syndrome (LS) is the most common inherited cause of colorectal and endometrial cancers. Identifying individuals at risk for LS without personal cancer history requires detailed collection and assessment of family health history. However, barriers exist to family health history collection, especially in historically underserved populations. To improve LS risk assessment in historically underserved populations, we adapted the provider-facing PREdiction Model for gene Mutations (PREMM 5 ™ model), a validated LS risk assessment model, into a patient-facing electronic application through an iterative development process involving expert and patient stakeholders. We report on preliminary findings based on the first 500 individuals exposed to the adapted application in a primary care population enriched for low-literacy and low-resource patients. Major adaptations to the PREMM 5 ™ provider module included reduction in reading level, addition of interactive literacy aids, incorporation of family history assessment for both maternal and paternal sides of the family, and inclusion of questions about individual relatives or small groups of relatives to reduce cognitive burden. In the first 500 individuals, 90% completed the PREMM 5 ™ independently; of those, 94% did so in 5 min or less (ranged from 0.2 to 48.8 min). The patient-facing application was able to accurately classify 84% of patients as having clinically significant or not clinically significant LS risk. Our preliminary results suggest that in this diverse study population, most participants were able to rapidly, accurately, and independently complete an interactive application collecting family health history assessment that accurately assessed for Lynch syndrome risk.

Bibliographic Information

JournalFamilial Cancer
PublisherSpringer
Publication Date2022-04-01
Publication Year2022
Volume21
Issue2
Pages167-180
Document TypeJournal Article
eISSN1573-7292
DOI10.1007/s10689-021-00243-3

Access Information

NARA Access Coverage2001-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10689
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.